J&J’s seltorexant meets all endpoints in Phase III MDD trial
In the Phase III trial, seltorexant as an adjuvant therapy helped MDD patients with symptoms of insominia.
30 May 2024
30 May 2024
In the Phase III trial, seltorexant as an adjuvant therapy helped MDD patients with symptoms of insominia.
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligent platform, has appointed George G Montgomery as Strategic Corporate Advisor to the Board.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
GlobalData’s AI governance framework helps senior executives identify all potential risks posed by AI systems and provides a checklist of questions to ask tech vendors during the procurement process to ensure they implement AI responsibly.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.